ANTEGRADE VERSUS ANTEGRADE* / RETROGRADE CARDIOPLEGIA FOR MYOCARDIAL PROTECTION IN PATIENTS UNDERGOING CORONARY ARTERY BYPASS GRAFTING

Abstract

Objective: Nonhomogeneous distribution of cardioplegia antegradely in severe coronary artery stenosis and evolving acute myocardial infarction has been demonstrated experimentally. Administration of cardioplegia retrogradely causes homogeneous distribution and offers a good alternative for myocardial protection.
Methods: Thirty five consecutive patients with three vessel-disease undergoing elective coronary artery bypass grafting were prospectively randomized to receive either antegrade cold blood cardioplegia alone (Group A, n: 17) or antegrade/retrograde cold blood cardioplegia (Group B, n: 18). The patients in group B received cardioplegia half dose antegradely and then the other half dose was given retrogradely. In both groups, following the induction dose of cold blood cardioplegia, 500 ml cold blood maintenance cardioplegia every 20 minutes and terminal warm blood cardioplegia were applied before the removal of the aortic cross clamp antegradely in group A and retrogradely in group B.
Results: Baseline patients characteristics did not differ in both groups. Myocardial temperature measured following the induction cardioplegia;
was significantly higher in group A than in group B (p<0.05). After 10 minutes of reperfusion, the rise in myocardial oxygen extraction and myocardial lactate extraction was higher in group A than in group B (p<0.02). CK-MB and Troponin-T levels at the postoperatively 12th hour were significantly higher in group A than in group B (p<0.05). Eight patients in group A, and 4 patients in group B inotropic support was used because of the low cardiac output (p: NS). However, when compared the inotropic score of the two groups, it was significantly higher in group A than in group B (2.1±0.6 in group A, 1.2+0.5 in group B p<0.04). In four patients in group A, 5 patients in group B atrial fibrillation, and in 5 patients in group A, 2 patients in group B ventricular extrasistole were observed (p:NS).
Conclusion: Antegrade/retrograde cardioplegia performs better protection and faster recovery than the antegrade cardioplegia alone.
Key Words: Antegrade, Retrograde,
Protection, CABG

References

1. Hilton CJ, Teubl W, Acker M, et al. Inadequate cardioplégie protection with obstructed coronary arteries. Ann Throac Surg 1979;28:323-334.
2. Gundiy SR, Hirsh MM. A comparison of retrograde cardioplegia versus antegrade cardioplegia in the presence of coronary artery obstruction. Ann Tliorac Surg 1984;38:124-127.
3. Buckberg GD. Antegrade / retrograde blood
4. cardioplegia to ensure cardioplégie distribution: operative techniques and
5. objectives. J Cardiac Surg 1989;4:216-238.
6. Menasche P, Subayi JB, Veyssie L, et al. Efficacy of coronary sinus cardioplegia in patients with complete coronary artery occlusions. Ann Thorac Surg 1991 ;51:418- 423.
7. Stirling MC, Mc Clanahan TB, Schott RJ, et al. Distribution of cardioplégie solution infused antegradely and retrogradely in normal canine hearts. J Thorac Cardiovasc Surg 1989;98:1066-1078.
8. Aldea 05, Hov D, Fonger JD, Slemin RJ. Inhomogeneous and complementary

9. Cardioplegia in CABG
10. antegrade and retrograde delivery of cardioplégie solution in the absence of coronary artery obstruction. J Thorac Cardiovasc Surg 1994; 107:499-504.
11. Bucberg GD. Antegrade cardioplegia, retrograde cardioplegia or both? Ann Thorac Surg 1988;46:589-590.
12. Crooke GA, Harris LJ, Grossi EA, et ai Biventricular distribution of cold blood cardioplégie solution administered by different retrograde techniques. J Throac Cardiovasc Surg 1991 ; 102:651 -657.
13. Partington AII, Acar C, Buckberg, CD, et al. Studies of retrograde cardioplegia. Capillary blood flow distribution to myocardium supplied by open and occluded arteries. J Thorac Cardiovasc Surg 1989:97:605-612.
14. Allen BS, Winkelmann JW, Hanafy H, et al. Retrograde cardioplegia does not adequately perfuse right ventricle. J Thorac Cardiovasc Surg 1995; 109:1116-1126.
15. Pichon H, Chocron S, Alman R, et al. Crystalloid versus cold blood cardioplegia and cardiac troponin I release. Circulation 1997 Jul 1:96:516-320.
16. Jegaden O, Eker A, Montagna P, et al. Antegradc/retrograde cardioplegia in arterial bypass grafting. Metabolic randomized clinical trial. Ann Thorac Surg 1995:59:456-461.
17. Elwatidy AMP, Eadallah MA, Bukhari EA, et al. Antegrade crystalloid cardioplegia ks antegrade/retrograde cold and tepid blood cardioplegia in CABG. Ann Thorac Surg 1999;68:447-453.
18. Carrier M, Pelletier LC, Searle, HR. Does retrograde administration of blood cardioplegia improve myocardial protection during first operation for coronary artery bypass grafting? Ann Thorac Surg 1997:64:1256-1262.
19. Hoyez L, Jam 1/5, Werf VD, et al. Retrograde versus antegrade delivery of cardioplegic solution in myocardial revascularization. A clinical trial In patients with three- vessel coronary artery disease who underwent myocardial revascularization with extensive use of internal mammary artery. J Thorac Cardiovasc Surg 1993; 105:854-863.
20. Gates RH, Laks H, Drinkwater DC, et al. Gross and microvascular distribution of retrograde cardioplegia in explanted human hearts, Ann Thorac Surg 1993:56:410-41 7.
21. I 7. Walter PJ, Elameng W, Rindl R, Podzuweit T. Preservation of myocardial energy-rich phosphates by retrograde application of Bretschneider cardioplegia during aorta- coronary bypass surgery. Eur J Cardiothorac Surg 1988;2:25-30.